HOME >> MEDICINE >> NEWS
COX inhibitors may weaken protective qualities of estrogen hormone therapy

PHILADELPHIA -- Researchers from the University of Pennsylvania School of Medicine found in a database study of women heart patients that COX inhibitors such as traditional nonsteroidal anti-inflammatory drugs (NSAIDs) may undermine any purported protection against heart disease in participants taking estrogen therapy. The results were described this week in PLoS Medicine.

Premenopausal women are less susceptible to heart attack and stroke than are males of the same age group, an advantage that is lost after menopause. However, why this happens physiologically is unclear. Despite the cardiovascular advantage of premenopausal women, it has been difficult to identify a cardioprotective effect of taking estrogen in postmenopausal women. The Penn research group recently found in mice that estrogen acts via COX-2dependent prostacyclin, a fat that has a role in limiting blood clotting. Estrogen in this animal model acts via prostacyclin to decrease clotting and oxidative stress in cells and to limit hardening of the arteries.

"We were prompted to perform these studies while exploring the mechanism by which NSAIDs confer a cardiovascular hazard, that is suppression of COX-2 derived prostacyclin" says lead author Garret FitzGerald, MD, Director of the Institute for Translational Medicine and Therapeutics at Penn.

Inhibition of COX-2 by NSAIDs prevents production of prostacyclin. However, as estrogen acts to increase production of prostacyclin, the researchers surmise that the possible positive effects of estrogen therapy on the cardiovascular system may be counteracted by the COX-inhibiting NSAIDs.

To ascertain whether the failure to detect a benefit from estrogen might be partly attributable to a pharmacological interaction between inhibitors of COX-2 and estrogen, the researchers examined the medical records of 1,673 women between 50 and 84 from the United Kingdoms General Practice Research Database who had heart attacks or wh
'"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
23-May-2007


Page: 1 2

Related medicine news :

1. ACE inhibitors help preserve kidney function in IgA nephropathy
2. Studies provide new evidence on risks associated with Cox-2 inhibitors and NSAIDs
3. Selective serotonin reuptake inhibitors antidepressants and risk of violent behavior
4. COX-2 inhibitors prescribed to reduce gastrointestinal toxicity prior to the market withdrawals
5. First trimester use of ACE inhibitors implicated in birth defects
6. Researchers resolve how COX inhibitors cause heart hazards, and offer alternative treatment strategy
7. ACE inhibitors may reduce death, heart attack and stroke in patients with coronary artery disease
8. COX-2 inhibitors significantly reduce risk of cancer
9. Regular use of selective COX-2 inhibitors decreases risk of breast cancer
10. Race/ethnicity predict lipids, heart-disease risk in HIV-1 patients on protease inhibitors
11. Blocking previously unrecognized links between inflammatory systems could make COX-2 inhibitors safe

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... ... September 25, 2017 , ... International Water Advocate ... Sharon Kleyne Hour Power of Water, Global Climate Change and Your Health on ... focus from a once-every-four-years series of events to a personal, daily Health Olympics. ...
(Date:9/25/2017)... ... September 25, 2017 , ... The Asset Tracking and Temperature monitoring system works ... as scanning the bar code of the product and lot ID then scanning the ... where violations are automatically generated and exception alerts sent out to designated individuals. , ...
(Date:9/25/2017)... ... 25, 2017 , ... Dr. Edward Hebert is celebrating his 33rd ... anything else,” said Dr. Hebert. “I count my blessings daily for the opportunity that ... patients is what I look forward to the most. The relationships I have with ...
(Date:9/25/2017)... Ignite Conference (PRWEB) , ... September 25, 2017 , ... ... have teamed up to deliver Netmail’s Hadron Data Auditing and eDiscovery ... Cloud. Netmail will be demo-ing their Hadron solution in a HIPAA/HITRUST Azure Cloud at ...
(Date:9/25/2017)... ... September 25, 2017 , ... ... September 28, 2017 to deliver a powerful message of teamwork, unity and collaboration ... Feature film writer/director Robert Adetuyi (Beat the World, Stomp the Yard) and Grammy-nominated ...
Breaking Medicine News(10 mins):
(Date:9/5/2017)... LONDON , Sept. 5, 2017  Just 18 ... Valid Insight is pleased to announce the appointment of ... Tammy Wynne , Dominic Jones-Phillips and ... from industry. ... a team of market access writers. She has over ...
(Date:9/1/2017)... 1, 2017 Michael Penna , President ... highlights opportunities for growth in his response to the ... Equity is seeking a buyer for eMDs. Penna,s company, ... healthcare solutions Value Added Reseller and national leader in ... "As the healthcare market continues to dictate ...
(Date:9/1/2017)... , Sept. 1, 2017  Bayer will present the ... European Society for Medical Oncology (ESMO) 2017 Congress, September 8-12 ... will include new preclinical and clinical data on Bayer,s marketed ... earlier pipeline projects. ... best minds in cancer research at ESMO," said Carsten ...
Breaking Medicine Technology:
Cached News: